Clinical trial
Inhibition by the Antibody, First Event of Infection by HIV-1 of Uterine Vaginal Tissue
NCT02481622 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhibition by the Antibody, First Event of Infection by HIV-1 of Uterine Vaginal Tissue
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- November 30, 2019
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection of the uterine vaginal tissues